Annual CFI
-$17.39 M
+$19.33 M+52.64%
31 December 2023
Summary:
Zevra Therapeutics annual cash flow from investing activities is currently -$17.39 million, with the most recent change of +$19.33 million (+52.64%) on 31 December 2023. During the last 3 years, it has fallen by -$17.36 million (-52596.97%). ZVRA annual CFI is now -152.17% below its all-time high of $33.33 million, reached on 01 December 2018.ZVRA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$31.35 M
-$31.23 M-24205.43%
30 September 2024
Summary:
Zevra Therapeutics quarterly cash flow from investing activities is currently -$31.35 million, with the most recent change of -$31.23 million (-24205.43%) on 30 September 2024. Over the past year, it has increased by +$13.10 million (+29.47%). ZVRA quarterly CFI is now -192.12% below its all-time high of $34.04 million, reached on 30 June 2023.ZVRA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$6.11 M
+$13.10 M+68.21%
30 September 2024
Summary:
Zevra Therapeutics TTM cash flow from investing activities is currently -$6.11 million, with the most recent change of +$13.10 million (+68.21%) on 30 September 2024. Over the past year, it has increased by +$21.93 million (+78.23%). ZVRA TTM CFI is now -115.04% below its all-time high of $40.58 million, reached on 01 June 2018.ZVRA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.6% | +29.5% | +78.2% |
| 3 y3 years | -10000.0% | -10000.0% | -5400.0% |
| 5 y5 years | -152.2% | -10000.0% | -154.5% |
ZVRA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | +52.6% | -192.1% | +29.5% | -136.6% | +88.3% |
| 5 y | 5 years | -152.2% | +52.6% | -192.1% | +29.5% | -136.6% | +88.3% |
| alltime | all time | -152.2% | +62.1% | -192.1% | +29.5% | -115.0% | +91.8% |
Zevra Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$31.35 M(>+9900.0%) | -$6.11 M(-68.2%) |
| June 2024 | - | -$129.00 K(-100.9%) | -$19.21 M(-228.4%) |
| Mar 2024 | - | $14.79 M(+39.8%) | $14.96 M(-186.0%) |
| Dec 2023 | -$17.39 M(-52.6%) | $10.59 M(-123.8%) | -$17.39 M(-38.0%) |
| Sept 2023 | - | -$44.46 M(-230.6%) | -$28.04 M(-268.0%) |
| June 2023 | - | $34.04 M(-293.9%) | $16.69 M(-133.1%) |
| Mar 2023 | - | -$17.55 M(>+9900.0%) | -$50.43 M(+37.3%) |
| Dec 2022 | -$36.72 M(+136.5%) | -$63.00 K(-123.2%) | -$36.72 M(-29.5%) |
| Sept 2022 | - | $272.00 K(-100.8%) | -$52.09 M(-0.5%) |
| June 2022 | - | -$33.08 M(+759.7%) | -$52.37 M(+170.3%) |
| Mar 2022 | - | -$3.85 M(-75.1%) | -$19.37 M(+24.8%) |
| Dec 2021 | -$15.52 M(>+9900.0%) | - | - |
| Dec 2021 | - | -$15.44 M(>+9900.0%) | -$15.52 M(>+9900.0%) |
| Sept 2021 | - | -$4000.00(-95.1%) | -$111.00 K(+3.7%) |
| June 2021 | - | -$81.00 K(<-9900.0%) | -$107.00 K(+386.4%) |
| Mar 2021 | - | $0.00(-100.0%) | -$22.00 K(-33.3%) |
| Dec 2020 | -$33.00 K(-101.0%) | -$26.00 K(<-9900.0%) | -$33.00 K(+175.0%) |
| Sept 2020 | - | $0.00(-100.0%) | -$12.00 K(-25.0%) |
| June 2020 | - | $4000.00(-136.4%) | -$16.00 K(-20.0%) |
| Mar 2020 | - | -$11.00 K(+120.0%) | -$20.00 K(-100.6%) |
| Dec 2019 | $3.23 M | -$5000.00(+25.0%) | $3.23 M(-71.1%) |
| Sept 2019 | - | -$4000.00(<-9900.0%) | $11.20 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $0.00(-100.0%) | $11.66 M(-57.3%) |
| Mar 2019 | - | $3.24 M(-59.3%) | $27.35 M(-18.0%) |
| Dec 2018 | $33.33 M(+21.6%) | $7.96 M(+1642.7%) | $33.33 M(-5.8%) |
| Sept 2018 | - | $457.00 K(-97.1%) | $35.38 M(-12.8%) |
| June 2018 | - | $15.68 M(+69.9%) | $40.58 M(+31.2%) |
| Mar 2018 | - | $9.23 M(-7.9%) | $30.94 M(+12.9%) |
| Dec 2017 | $27.41 M(-159.8%) | $10.02 M(+77.1%) | $27.41 M(+18.5%) |
| Sept 2017 | - | $5.66 M(-6.4%) | $23.14 M(+9.7%) |
| June 2017 | - | $6.04 M(+5.9%) | $21.09 M(-183.0%) |
| Mar 2017 | - | $5.70 M(-0.6%) | -$25.41 M(-44.6%) |
| Dec 2016 | -$45.85 M(+139.6%) | $5.74 M(+58.8%) | -$45.85 M(-35.1%) |
| Sept 2016 | - | $3.62 M(-108.9%) | -$70.63 M(-4.9%) |
| June 2016 | - | -$40.47 M(+174.7%) | -$74.30 M(+119.5%) |
| Mar 2016 | - | -$14.73 M(-22.6%) | -$33.85 M(+76.9%) |
| Dec 2015 | -$19.14 M(>+9900.0%) | -$19.04 M(>+9900.0%) | -$19.14 M(>+9900.0%) |
| Sept 2015 | - | -$55.00 K(+189.5%) | -$125.00 K(+64.5%) |
| June 2015 | - | -$19.00 K(-9.5%) | -$76.00 K(+18.8%) |
| Mar 2015 | - | -$21.00 K(-30.0%) | -$64.00 K(+36.2%) |
| Dec 2014 | -$47.00 K(+38.2%) | -$30.00 K(+400.0%) | -$47.00 K(+176.5%) |
| Sept 2014 | - | -$6000.00(-14.3%) | -$17.00 K(+54.5%) |
| June 2014 | - | -$7000.00(+75.0%) | -$11.00 K(+175.0%) |
| Mar 2014 | - | -$4000.00 | -$4000.00 |
| Dec 2013 | -$34.00 K | - | - |
FAQ
- What is Zevra Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Zevra Therapeutics?
- What is Zevra Therapeutics annual CFI year-on-year change?
- What is Zevra Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly CFI year-on-year change?
- What is Zevra Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Zevra Therapeutics?
- What is Zevra Therapeutics TTM CFI year-on-year change?
What is Zevra Therapeutics annual cash flow from investing activities?
The current annual CFI of ZVRA is -$17.39 M
What is the all time high annual CFI for Zevra Therapeutics?
Zevra Therapeutics all-time high annual cash flow from investing activities is $33.33 M
What is Zevra Therapeutics annual CFI year-on-year change?
Over the past year, ZVRA annual cash flow from investing activities has changed by +$19.33 M (+52.64%)
What is Zevra Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ZVRA is -$31.35 M
What is the all time high quarterly CFI for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly cash flow from investing activities is $34.04 M
What is Zevra Therapeutics quarterly CFI year-on-year change?
Over the past year, ZVRA quarterly cash flow from investing activities has changed by +$13.10 M (+29.47%)
What is Zevra Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ZVRA is -$6.11 M
What is the all time high TTM CFI for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM cash flow from investing activities is $40.58 M
What is Zevra Therapeutics TTM CFI year-on-year change?
Over the past year, ZVRA TTM cash flow from investing activities has changed by +$21.93 M (+78.23%)